Erschienen in:
16.04.2021 | Special Section: HCC treatment
Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention
verfasst von:
Joseph H. Yacoub, David Mauro, Andrew Moon, Aiwu R. He, Mustafa R. Bashir, Christine C. Hsu, Thomas M. Fishbein, Lauren M. B. Burke
Erschienen in:
Abdominal Radiology
|
Ausgabe 8/2021
Einloggen, um Zugang zu erhalten
Abstract
Locoregional therapies can be offered to hepatocellular carcinoma patients as a bridge to transplant, to downstage disease burden for transplant eligibility, or for disease control to prolong survival. Systemic therapies also play a large role in HCC treatment, occasionally in conjunction with other methods. This manuscript reviews the various treatment options for HCC with a historically noncurative intent.